{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:58:13Z","timestamp":1762444693839},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,5]]},"DOI":"10.18632\/oncotarget.18816","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T14:13:27Z","timestamp":1498745607000},"page":"62039-62048","source":"Crossref","is-referenced-by-count":9,"title":["Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function"],"prefix":"10.18632","volume":"8","author":[{"given":"Sandro","family":"Gentile","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Campania, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The AMD-Annals Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Piscitelli","sequence":"additional","affiliation":[{"name":"IRCSS Casa Sollievo della Sofferenza - Unit of Internal Medicine, Scientific Institute, San Giovanni Rotondo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[{"name":"Insititut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), Barcelona, Spain"},{"name":"U.O. Diabetologia e Malattie Metaboliche, Multimedica IRCCS, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giorda","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism Unit, ASL Turin 5, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Guida","sequence":"additional","affiliation":[{"name":"Statistical Consultant for Associazione Medici Diabetologi (AMD), Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pontremoli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice","family":"Strollo","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, Elle-di, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[{"name":"IRCSS Casa Sollievo della Sofferenza - Unit of Internal Medicine, Scientific Institute, San Giovanni Rotondo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"1","unstructured":"World Health Organization (WHO). Diabetes Fact sheet. Reviewed November 2016 WHO website. http:\/\/www.who.int\/mediacentre\/factsheets\/fs312\/en\/ 17 January 2017."},{"key":"2","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.2337\/dc17-S011","article-title":"Pharmacologic approaches to glycemic treatment","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"key":"3","unstructured":"National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline [NG28]. Published date: December 2015."},{"key":"4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1464-5491.2001.00509.x","article-title":"Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines","volume":"18","author":"Morris","year":"2001","journal-title":"Diabet Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.20.6.925","article-title":"Contraindications to metformin therapy in patients with NIDDM","volume":"20","author":"Krentz","year":"1997","journal-title":"Diabetes Care"},{"key":"6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-5491.1999.00115.x","article-title":"Contra-indications to metformin therapy are largely disregarded","volume":"16","author":"Egberts","year":"1999","journal-title":"Diabet Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"8","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"McGuire","year":"2014","journal-title":"JAMA"},{"key":"9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M16-1901","article-title":"Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review","volume":"166","author":"Williams","year":"2017","journal-title":"Ann Intern Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"e001076","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register","volume":"2","author":"Gudbj\u00f6rnsdottir","year":"2012","journal-title":"BMJ Open"},{"key":"11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jama.2015.8345","article-title":"Glycemic control in older adults with diabetes mellitus","volume":"314","author":"Davis","year":"2015","journal-title":"JAMA"},{"key":"12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study","volume":"3","author":"Tarng","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"13","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.clinthera.2009.10.020","article-title":"Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States","volume":"31","author":"Bowlin","year":"2009","journal-title":"Clin Ther"},{"key":"14","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2215\/CJN.03140315","article-title":"Serum uric acid and risk of CKD in type 2 diabetes","volume":"10","author":"Pontremoli","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-154-8-201104190-00007","article-title":"Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials","volume":"154","author":"Genuth","year":"2011","journal-title":"Ann Intern Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/dmrr.2722","article-title":"Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany\/Austria: how big is the problem? Which patients are at risk?","volume":"32","author":"Holl","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.diabres.2015.09.006","article-title":"Severe hypoglycemia during treatment with sulphonilureas in patients with type 2 diabetes in the Capital Region of Denmark","volume":"110","author":"R\u00f8der","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"18","first-page":"854","article-title":"UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","year":"1998","journal-title":"Lancet"},{"key":"19","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"de Vries","year":"2014","journal-title":"Diabetes Care"},{"key":"20","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Gottwald-Hostalek","year":"2014","journal-title":"Diabetes Care"},{"key":"21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.diabres.2015.01.041","article-title":"Metformin utilisation in Australian community and aged care settings","volume":"108","author":"Castelino","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"22","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/jgs.13790","article-title":"Use of renally inappropriate medications in older veterans: a national study","volume":"63","author":"Steinman","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"23","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Rubin","year":"1999","journal-title":"JAMA"},{"key":"24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Barnes","year":"2001","journal-title":"Ann Intern Med"},{"key":"25","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1517\/14656560903391714","article-title":"Biphasic insulin aspart in the treatment of type 2 diabetes mellitus","volume":"10","author":"Russo","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"26","unstructured":"Osservatorio ARNO Diabete Il profilo assistenziale della popolazione con diabete http:\/\/www.siditalia.it\/images\/Documenti\/NEWS\/Rapporto_Arno_Diabete_2015.pdf, 15 January 2015."},{"key":"27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Coresh","year":"2009","journal-title":"Ann Intern Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/dc10-1709","article-title":"AMD-QUASAR Study Group. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study","volume":"34","author":"Nicolucci","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:19:01Z","timestamp":1596730741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":28,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2017,9,5]]}},"alternative-id":["18816","28977924"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18816","relation":{},"ISSN":["1949-2553"],"issn-type":[{"type":"electronic","value":"1949-2553"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}